抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
SKF-86002，99% | C16H12FN3S | |||
|
|
|||||
|
FMK，≥98% | C18H19FN4O2 | |||
|
|
|||||
|
Bentamapimod ( AS 602801)，98% | C25H23N5O2S | |||
|
|
|||||
|
RO4987655(CH4987655)，98% | C20H19F3IN3O5 | |||
|
|
|||||
|
BRAF inhibitor，98% | C22H18F2N4O3S | |||
|
|
|||||
|
DB07268，98% | C17H15N5O2 | |||
|
|
|||||
|
|
XL-518 raceMate，99% | C21H21F3IN3O2 | |||
|
|
|||||
|
B-Raf IN 1，98% | C29H24F3N5O | |||
|
|
|||||
|
GDC-0994，98% | C21H18ClFN6O2 | |||
|
|
|||||
|
LJI308，99% | C21H18F2N2O2 | |||
|
|
|||||
|
TAK-715，99% | C24H21N3OS | |||
|
|
|||||
|
SB590885，98% | C27H27N5O2 | |||
|
|
|||||
|
PLX-4720，99% | C17H14ClF2N3O3S | |||
|
|
|||||
|
SCH772984，98% | C34H34N8O2 | |||
|
|
|||||
|
LY-2584702 (free base)，99% | C21H19F4N7 | |||
|
|
|||||
|
|
MLN2480，≥98% | C17H12Cl2F3N7O2S | |||
|
|
|||||
|
PLX7904，97% | C24H22F2N6O3S | |||
|
|
|||||
|
XMD17-109，99% | C36H46N8O3 | |||
|
|
|||||
|
APS-2-79 (hydrochloride)，98% | C23H22ClN3O3 | |||
|
|
|||||
|
PLURIPOTIN，98% | C27H25F3N8O2 | |||
|
|
|||||
|
BI-78D3，99% | C13H9N5O5S2 | |||
|
|
|||||
|
CC-930，98% | C21H23F3N6O2 | |||
|
|
|||||
|
|
Refametinib，≥98% | C19H20F3IN2O5S | |||
|
|
|||||
|
Ro 5126766，97% | C21H18FN5O5S | |||
|
|
|||||
|
MK2-IN-1 (hydrochloride)，99% | C27H26Cl2N4O2 | |||
|
|
|||||
|
AX-15836，98% | C32H40N8O5S | |||
|
|
|||||
|
ERK5-IN-2，98% | C17H11BrFN3O2 | |||
|
|
|||||
